Those in favor of the classification argue that excess fat accumulation/distribution is linked to sustained and serious ...

Policymakers should focus on both obesity prevention and better access to treatment for those already living with obesity.

A new sub-analysis of the SELECT trial data shows semaglutide 2.4 mg substantially reduces the burden of total cardiovascular ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

Obesity remains a global health crisis, often linked to serious diseases such as diabetes, heart disease, and fatty liver ...

Type 2 diabetes is a disease that involves your blood glucose (also known as blood sugar) being too high, and obesity is a major risk factor that can make you more likely to develop it.

Drinking sugar-sweetened beverages may increase your risk of heart disease. These drinks are easy to overconsume and provide ...

Pancreatic cancer, one of the deadliest types of the disease, has been linked to obesity and higher stress levels, a new UCLA ...

Responding to the progress of its obesity pipeline, the Chinese biotech is stepping up its investment in metabolic disease ...

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...